An update on the diagnosis and treatment of leprosy.
Moschella
Samuel L
SL
Department of Dermatology, Lahey Clinic Medical Center, Burlington, MA 01805, USA. Samuel_L_Moschella@lahey.org
D001428:Bacterial Vaccines; D004359:Drug Therapy, Combination; D005260:Female; D014943:Global Health; D015658:HIV Infections / Q000150:complications; D006801:Humans; D016233:Immunotherapy, Active; D015994:Incidence; D007916:Lepromin; D007917:Leprostatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007918:Leprosy / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control / Q000534:rehabilitation / Q000628:therapy; D008297:Male; D009166:Mycobacterium leprae / Q000276:immunology / Q000302:isolation & purification; D010523:Peripheral Nervous System Diseases / Q000209:etiology / Q000517:prevention & control / Q000534:rehabilitation; D010808:Physical Examination; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011248:Pregnancy Complications; D015995:Prevalence; D012680:Sensitivity and Specificity; D014611:Vaccination; D014944:World Health Organization
D001428:Bacterial Vaccines; D007917:Leprostatic Agents; D007916:Lepromin